1. Home
  2. EVOK vs SGLY Comparison

EVOK vs SGLY Comparison

Compare EVOK & SGLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVOK
  • SGLY
  • Stock Information
  • Founded
  • EVOK 2007
  • SGLY 2001
  • Country
  • EVOK United States
  • SGLY United States
  • Employees
  • EVOK N/A
  • SGLY N/A
  • Industry
  • EVOK Biotechnology: Pharmaceutical Preparations
  • SGLY
  • Sector
  • EVOK Health Care
  • SGLY
  • Exchange
  • EVOK Nasdaq
  • SGLY Nasdaq
  • Market Cap
  • EVOK 5.4M
  • SGLY 4.5M
  • IPO Year
  • EVOK 2013
  • SGLY 2008
  • Fundamental
  • Price
  • EVOK $5.12
  • SGLY $1.26
  • Analyst Decision
  • EVOK
  • SGLY
  • Analyst Count
  • EVOK 0
  • SGLY 0
  • Target Price
  • EVOK N/A
  • SGLY N/A
  • AVG Volume (30 Days)
  • EVOK 432.5K
  • SGLY 61.9K
  • Earning Date
  • EVOK 11-06-2025
  • SGLY 11-13-2025
  • Dividend Yield
  • EVOK N/A
  • SGLY N/A
  • EPS Growth
  • EVOK N/A
  • SGLY N/A
  • EPS
  • EVOK N/A
  • SGLY N/A
  • Revenue
  • EVOK $12,794,859.00
  • SGLY $2,172,036.00
  • Revenue This Year
  • EVOK $57.38
  • SGLY N/A
  • Revenue Next Year
  • EVOK $59.57
  • SGLY N/A
  • P/E Ratio
  • EVOK N/A
  • SGLY N/A
  • Revenue Growth
  • EVOK 70.02
  • SGLY N/A
  • 52 Week Low
  • EVOK $1.94
  • SGLY $0.54
  • 52 Week High
  • EVOK $12.32
  • SGLY $5.49
  • Technical
  • Relative Strength Index (RSI)
  • EVOK 49.82
  • SGLY 65.52
  • Support Level
  • EVOK $5.00
  • SGLY $1.11
  • Resistance Level
  • EVOK $5.27
  • SGLY $1.45
  • Average True Range (ATR)
  • EVOK 0.22
  • SGLY 0.10
  • MACD
  • EVOK -0.05
  • SGLY 0.02
  • Stochastic Oscillator
  • EVOK 38.91
  • SGLY 62.75

About EVOK Evoke Pharma Inc.

Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.

About SGLY Singularity Future Technology Ltd.

Singularity Future Technology Ltd is an investment holding company. The company's operating segment includes Freight Logistics Services and Sale of Crypto-mining Machines. It generates maximum revenue from the Freight Logistics Services segment. Geographically, it derives a majority of its revenue from China.

Share on Social Networks: